Assyro AI

Orange Book product · Brand (NDA)

BREKIYA (AUTOINJECTOR)

DIHYDROERGOTAMINE MESYLATE

Brand (NDA)NDA 215400RX AMNEAL

At a glance

May 14, 2025

Approved

Brand (NDA)

Application

Not listed

TE code

11

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 14, 2025

    1 yr 1 mo ago

  2. Today

  3. Patent 10532049 expires

    Listed drug product patent expiration.

    Feb 26, 2039

    in 12 yr 11 mo

  4. Patent 11304942 expires

    Listed drug product patent expiration.

    Feb 26, 2039

    in 12 yr 11 mo

  5. Patent 11819501 expires

    Listed method-of-use patent (U-848) expiration.

    Feb 26, 2039

    in 12 yr 11 mo

  6. Patent 11819501 expires

    Listed method-of-use patent (U-4188) expiration.

    Feb 26, 2039

    in 12 yr 11 mo

  7. Patent 12533351 expires

    Listed drug product patent expiration.

    Feb 26, 2039

    in 12 yr 11 mo

  8. Patent 11541043 expires

    Listed drug product patent expiration.

    Mar 20, 2039

    in 12 yr 11 mo

  9. Patent 12329749 expires

    Listed drug product patent expiration.

    May 27, 2039

    in 13 yr 2 mo

  10. Patent 12329749 expires

    Listed drug product patent expiration.

    May 27, 2039

    in 13 yr 2 mo

  11. Patent 11083712 expires

    Listed drug product patent expiration.

    Jun 30, 2039

    in 13 yr 3 mo

  12. Patent 11083712 expires

    Listed drug product patent expiration.

    Jun 30, 2039

    in 13 yr 3 mo

  13. Patent 12414941 expires

    Listed drug product patent expiration.

    Aug 24, 2039

    in 13 yr 4 mo

Pharmaceutical detail

Active ingredient

DIHYDROERGOTAMINE MESYLATE

Strength

1MG/ML

Dosage form

SOLUTION

Route

SUBCUTANEOUS

TE code

Not listed

Application

NDA 215400

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (11)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10532049Feb 26, 2039in 12 yr 11 mo
Product
11304942Feb 26, 2039in 12 yr 11 mo
Product
11819501Feb 26, 2039in 12 yr 11 mo
U-848
11819501Feb 26, 2039in 12 yr 11 mo
U-4188
12533351Feb 26, 2039in 12 yr 11 mo
Product
11541043Mar 20, 2039in 12 yr 11 mo
Product
12329749May 27, 2039in 13 yr 2 mo
ProductU-2718
12329749May 27, 2039in 13 yr 2 mo
ProductU-4508
11083712Jun 30, 2039in 13 yr 3 mo
ProductU-2718
11083712Jun 30, 2039in 13 yr 3 mo
ProductU-4508
12414941Aug 24, 2039in 13 yr 4 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.